The Effect of Vitamin D Supplementation on Disease Activity and Neutrophyl-Lymphocyte Count Ratio in Systemic Lupus Erythematosus Patients with Hypovitaminosis D : A Preliminary Study

Main Article Content

Y Maslim
Sumartini Dewi
A Oehadian
Rachmat Gunadi Wachjudi

Abstract

Background : Previous studies showed a significant role of Vitamin D in modulating inflammation and immune abnormality in SLE. The correlation between vitamin D supplementation and SLE disease activity remains controversy. Neutrophyl-Lymphocyte count Ratio (NLCR) as an inflammation marker was significantly increased in SLE patients.Objective : To evaluate the effect of vitamin D supplementation on disease activity and neutrophyllypmhocyte count ratio (NLCR) in SLE patients with hypovitaminosis D.Methods : This is a pre-post test study without control group using a consecutive sampling method. SLE patients were enrolled from Rheumatology Clinic of HasanSadikin General Hospital from November 2013-March 2014. Subjects received vitamin D3 2000 IU/day for 3 months. Data was analyzed using Wilcoxon test.Results : We analyzed 28 subjects with 89,3% of vitamin D deficiency and 10,7% of vitamin D insufficiency, which converted to 25% of vitamin D deficiency, 32,1% vitamin D insufficiency and 42,9% normal vitamin D plasma level at the end of the study.After supplementation, Mexican Systemic Lupus Erythematosus Disease Activity Index (MEX-SLEDAI) and NLCR was significantly decreased (median 4(3-8) to 2(0-6) and median 2,95(1,17-7,27) to 2,28 (1,07-4,87), p<0,001, respectively). SLE organ involvement such as mucocutan, hematology and renal also high BMI (>23 kg/m2) were risks of hypovitaminosis D. Vitamin D supplementation increased mean 25(OH)D serum level by 164,7%, 46,7% decreased of MEX-SLEDAI, and 24,2% decreased of NLCR (p<0,001). Nine subjects (32,1%) achieved remission, 19 subjects (67,9%) atdisease persistence and no subjects experienced flare up after supplementation.Conclusion : The effects of vitamin D3 2000 IU/day supplementation for 3 months are reduced disease activity and NLCR in SLE patients with hypovitaminosisD. The role of NLCR as a simple inflammation marker in this pilot study needs further investigation.

Article Details

How to Cite
Maslim, Y., Dewi, S., Oehadian, A., & Wachjudi, R. (2018). The Effect of Vitamin D Supplementation on Disease Activity and Neutrophyl-Lymphocyte Count Ratio in Systemic Lupus Erythematosus Patients with Hypovitaminosis D : A Preliminary Study. Indonesian Journal of Rheumatology, 5(1). https://doi.org/10.37275/ijr.v5i1.48
Section
Original Article

References

1. Bertoli AM, Alarcon GS. Epidemiology of systemic lupus erythematosus. Dalam: Tsokos GC, Gordon C, Smolen JS, editor. Systemic lupus erythematosus. Edisi ke-1. Philadelphia: Elsevier; 2007. h.1−14.
2. Christi L, Hamijoyo L, Dewi S, Rahmadi AR, Gunadi R, Pramudiyo R. Manifestasi klinis awal, dan perjalanan penyakit pasien lupus eritematosus sistemik RS Dr Hasan Sadikin Bandung. Dilaporkan pada Reumatologi Klinik Bandung. Bandung, 2012.
3. Vidyaniati P, Pramudiyo P. Prevalensi penyakit reumatik di poliklinik reumatologi RS Dr Hasan Sadikin bulan Januari 2012-Desember 2012. Dilaporkan pada Temu Ilmiah Reumatologi 2013.
4. Hahn BH. Overview of pathogenesis of systemic lupus erythematosus.Dalam: Wallace DJ, Hahn BH, editor. Dubois’ Lupus Erythematosus. Edisi ke-7. Los Angeles: Lippincott Williams & Wilkins; 2007. h.47−52.
5. Tsokos GC. Mechanisms of disease systemic lupus erythematosus. N Engl J Med 2011;365:2110−21.
6. Rekomendasi perhimpunan reumatologi Indonesia untuk diagnosis dan pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Reumatologi Indonesia; 2011. h. 3-28, 35.
7. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007;66:1137-1142.
8. Robinson AB, Thierry-Palmer M, Gibson KL, Rabinovich CE. Disease activity, proteinuria and vitamin D status in children with Systemic Lupus Erythematosus and Juvenile dermatomyositis. J Pediatr 2012; 160: 297-302.
9. Ritterhouse LL, Crowe SR, Niewold TB, Kamen DL, Macwana SR, Roberts VC, dkk. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 2011; 70: 1569-74.
10. Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: prevalen ce, predictors and clinical consequences.Rheumatology 2008; 47:920-923.
11. Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T, dkk. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity : is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010; 69 : 1155-1157.
12. Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C, Zabek J, Kontny E, dkk. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus 2012; 21: 477-484.
13. Abou-Raya A, Abou-Raya S, Helmii M. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus : A Radomized Placebo-controlled Trial. J Rheumatol 2013; 40: 265-72.
14. Terrier B, Derian N, Schoindre Y, Chaara W, Geri G, dkk. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D suppplementation. Arthritis Research and Therapy 2012; 14: R 221.
15. Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008; 67 : 530-535.
16. Lee YH, Bae SC, Choi SJ, Ji JD, Song GG. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 2011;38(6):3643−51.
17. Singh A, Kamen DL. Potential benefits of vitamin D for patients with systemic lupus erythematosus. Dermato-Endocrinology 2012; 4(2):146-51.
18. Sakthiswary S, Raymond AA. The Clinical Significance of Vitamin D inSystemic Lupus Erythematosus : A Systematic Review. PloS ONE 2013;8 (1) : e 55275.
19. Borba VZC, Vieira JGH, Kasamatsu T, Radominski SC, Sato EI, LazarettiCastro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 2009; (20) : 427-433.
20. Kurniati NME, Musal M, Salim MS. The Effectivity of Vitamin D3 Supplementation on Systemic Lupus Erythematosus (SLE) Disease Activity (MEX-SLEDAI) and Vitamin D Level Among SLE Patients. (diunduh 1 Februari 2013). Tersedia dari: http://www.fk.unair.ac.id/index.php
21. Handono K, Puspitasari L, Rudijanto A, Wahono S, Kalim H. Vitamin D serum level and disease activity in patients with systemic lupus erythematosus. International Journal of Pharmaceutical Science Invention 2013; 2 (2): 35-40.
22. Nureka M. Perbedaan kadar vitamin D pasien lupus eritematosus sistemik aktif dan tidak aktif. Disampaikan pada Pendidikan Kedokteran Berkelanjutan Ilmu Penyakit Dalam XII-2013.
23. Quismorio FP. Hematologic and lymphoid abnormalities in Systemic Lupus Erythematosus. In: Wallace DJ, Hahn BH,editors. Dubois’Lupus Erythematosus. 7th ed. Philadelphia : Lippincott William &Wilkins;2007:801-20.
24. Oehadian A, Suryadinata H, Dewi S, Pramudyo R, Alisjahbana B. TheRole of Neutrophyl Lymphocyte Count Ratio as an Inflammatory Marker in Systemic Lupus Erythematosus. Acta Med Indones-Indones J Intern Med 2013;45(3):170-174.
25. Zazula AD, Precoma-Neto, Gomes AM, Kruklis H, Barbieri GF, Forte RY, dkk.
Assessment of Neutrophils/Lymphocytes Ratio in Patients Suspected of Acute Coronary Syndrome. Arq Bras Cardiol 2008; 90(1):30-35.
26. Selcuk H, Dinc L, Selcuk MT, Maden O, Temizhan A. The relation between differential leukocyte count, neutrophil to lymphocyte ratio and the presence and severity of coronary artery disease. Open Journal of Internal Medicine 2012; 2: 163-169.
27. Celikbilek M, Dogan S, Ozbakir O, Zararsiz G, Hamit K, Gursoy S, dkk. Neutrophil-Lymphocyte Ratio as a predictor of disease severity in Ulcerative Colitis. J Clin Lab Anal 2013; 27 : 72-76.
28. Petri M, Orbai A, Alarco’n GS, Gordon C, Merrill JT, Fortin PR dkk. Derivation and validation of the Systemic Lupus International Collaboratin Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatism 2012;64(8):2677-2686.
29. Guzman J, Cardiel MH, Arce-Salinas A, Sanches-Guerrero J, AlarconSegovia D. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol1992;19(10):1551−8.
30. Galarza-Maldonado C, Kourilovitch MR, Molineros JE, Cardiel MH, Zurita L, Soroka NF, dkk. The administration of low dose of rituximab followed by hydroxychloroquine, prednisone and low dose of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus. Autoimmun Rev 2010;10:108−11.
31. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, dkk. Evaluation, Treatment, and Prevention of Vitamin D Deficiency : an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96 : 1911-1930.
32. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guidelines for the Evaluation and Management of Chronic Kidney Disease. Kidney Inter., Suppl.2013; 3:1- 150.
33. Kim BK, Han KH, Ahn SH. “Normal” range of alanine aminotransferase levels for Asian population. J. Gastroenterol. Hepatol 2011; 26: 292-299.
34. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Archives of Dermatology 1988; 124(6):869-71.
35. Khan QJ, Fablan CJ. How I Treat Vitamin D Deficiency. (diunduh 5 Maret 2013). Tersedia dari : http//www.jop.ascopubs.org
36. Petri M, Bello KJ, Fang H, Magder LS.Vitamin D in systemic lupus erythematosus : modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum 2013 Jul;65(7):1865–71.
37. Dan JQ, Zhang YJ, Peng ZW, Huang JT, Gao HJ, Chen MS, dkk. Postoperative Neutrophyl-to-lymphocyte ratio change predicts survival of Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.PLoS ONE 2013; 8(3) e58184.
38. van Wolfsminkel ME, Vliegenthart-Jongbloed K, de Melo MM, Wever PC, McCall MB, Koelewijn R, dkk. Predictive value of lymphocytopenia and the neutrophyl-lymphocyte count ratio for severe imported malaria. Malaria Journal 2013; 12 : 101.
39. Sterling KL, Gallop K, Swinburn P, Flood E, French A, Al Sawah S, dkk. Patient-reported fatigue and its impact on patients with systemic lupus erythematosus. Lupus 2014 (23): 124-32.